Bryn Mawr Capital Management LLC reduced its stake in shares of SelectQuote, Inc. (NYSE:SLQT – Free Report) by 84.7% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 49,211 shares of the company’s stock after selling 273,369 shares during the period. Bryn Mawr Capital Management LLC’s holdings in SelectQuote were worth $183,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Rhumbline Advisers boosted its stake in SelectQuote by 2.6% in the fourth quarter. Rhumbline Advisers now owns 209,743 shares of the company’s stock worth $780,000 after buying an additional 5,235 shares in the last quarter. SG Americas Securities LLC lifted its holdings in shares of SelectQuote by 10.5% in the 4th quarter. SG Americas Securities LLC now owns 91,508 shares of the company’s stock worth $340,000 after acquiring an additional 8,660 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of SelectQuote by 36.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 429,656 shares of the company’s stock valued at $932,000 after purchasing an additional 115,865 shares in the last quarter. Virtu Financial LLC bought a new position in shares of SelectQuote during the 3rd quarter valued at $150,000. Finally, Barclays PLC raised its position in SelectQuote by 166.8% in the 3rd quarter. Barclays PLC now owns 198,357 shares of the company’s stock worth $430,000 after purchasing an additional 124,005 shares during the period. 34.59% of the stock is currently owned by hedge funds and other institutional investors.
SelectQuote Trading Down 16.8 %
NYSE:SLQT opened at $4.57 on Friday. The firm has a market capitalization of $785.82 million, a P/E ratio of -50.72 and a beta of 1.15. The company has a quick ratio of 6.36, a current ratio of 6.36 and a debt-to-equity ratio of 2.10. The company has a fifty day moving average of $4.26 and a 200 day moving average of $3.23. SelectQuote, Inc. has a 52 week low of $1.48 and a 52 week high of $6.86.
Wall Street Analyst Weigh In
Several research firms have issued reports on SLQT. Noble Financial upgraded shares of SelectQuote to a “strong-buy” rating in a research report on Wednesday, February 12th. Royal Bank of Canada restated a “sector perform” rating and set a $4.00 target price on shares of SelectQuote in a report on Friday, November 22nd.
Get Our Latest Stock Analysis on SLQT
SelectQuote Company Profile
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Further Reading
- Five stocks we like better than SelectQuote
- When to Sell a Stock for Profit or Loss
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- 3 Healthcare Dividend Stocks to Buy
- DuPont’s Electronics Spinoff: The Start of Something Big
- Financial Services Stocks Investing
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding SLQT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SelectQuote, Inc. (NYSE:SLQT – Free Report).
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.